HER2 status in patients with breast carcinoma is not modified selectively by preoperative chemotherapy and is stable during the metastatic processAnne Vincent‐Salomon(Institut Curie), Xavier Sastre‐Garau(Institut Curie)CancerApril 15, 200210.1002/cncr.10456Cited by 114SaveCiteExport RISWatch citationsRelated PapersCalibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French Multicentre GEFPICS* Study|Histopathology|2003|121